Related Experiment Video
Updated: Jul 5, 2026
Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction
Published on: May 28, 2012
The potential of various lipopolysaccharides to release IL-8 and G-CSF
Abstract:
Lipopolysaccharide (LPS) derived from Pseudomonas aeruginosa is less cytotoxic than that from Escherichia coli. But P. aeruginosa induces a prominent sustained lung inflammation as in cystic fibrosis and diffuse panbronchiolotis. The present study examined the potential for several LPSs obtained from E. coli and P. aeruginosa to release neutrophil chemotactic activity (NCA) from lung cells. LPSs differently stimulated A549 cells, BEAS-2B cells, and lung fibroblasts to release NCA [P. aeruginosa > E. coli 0127:B8 (Difco) > E. coli 055:B5 (Sigma) > E. coli 026:B6 (Sigma)]. E. coli 0127:B8 (Sigma) and 0111:B4 (Sigma) did not stimulate these cells. NCA was chemotactic by checkerboard analysis. Molecular-sieve column chromatography revealed three chemotactic peaks. The release of NCA was inhibited by cycloheximide and lipoxygenase inhibitors. Experiments with blocking antibodies suggested that much of the NCA was secondary to the release of interleukin (IL)-8 and granulocyte colony-stimulating factor (G-CSF). Thus we examined the concentrations of IL-8 and G-CSF and found that the potency of the various LPSs to stimulate NCA closely paralleled the potency in releasing IL-8 and G-CSF. But a difference among LPSs to stimulate A549 cells was observed. Finally, the release of IL-6 showed similar results. These data suggest that P. aeruginosa LPS may stimulate lung cells to release more NCA than E. coli LPSs, leading to sustained lung inflammation.
Insights
Pseudomonas aeruginosa lipopolysaccharide (LPS) stimulates lung cells to release more neutrophil chemotactic activity (NCA) than Escherichia coli LPS. This contributes to sustained lung inflammation, observed in conditions like cystic fibrosis.
Area of Science:
- Immunology
- Microbiology
- Pulmonary Medicine
Background:
- Lipopolysaccharide (LPS) from Pseudomonas aeruginosa causes sustained lung inflammation, distinct from the lower cytotoxicity of Escherichia coli LPS.
- Understanding the mechanisms of LPS-induced lung inflammation is crucial for treating conditions like cystic fibrosis and diffuse panbronchiolitis.
Purpose of the Study:
- To investigate the differential capacity of various LPSs from P. aeruginosa and E. coli to induce neutrophil chemotactic activity (NCA) release from human lung cells.
- To identify the specific inflammatory mediators involved in LPS-stimulated NCA release and their correlation with observed inflammatory responses.
Main Methods:
- Exposure of human lung cell lines (A549, BEAS-2B) and lung fibroblasts to different bacterial LPS preparations.
- Quantification of released NCA using checkerboard analysis and molecular-sieve column chromatography.
- Assessment of inflammatory mediator release, including interleukin-8 (IL-8), granulocyte colony-stimulating factor (G-CSF), and interleukin-6 (IL-6), using blocking antibodies and concentration assays.
Main Results:
- P. aeruginosa LPS demonstrated a significantly higher potency in stimulating NCA release compared to E. coli LPS across tested lung cells.
- The release of NCA was strongly correlated with the increased concentrations of IL-8 and G-CSF, suggesting their central role in the inflammatory cascade.
- Differential stimulation of A549 cells by various LPSs was observed, alongside similar patterns for IL-6 release.
Conclusions:
- P. aeruginosa LPS is a potent stimulator of NCA release from lung cells, exceeding the activity of E. coli LPS.
- The findings highlight the role of IL-8 and G-CSF in mediating LPS-induced lung inflammation, potentially explaining the sustained inflammatory response seen in certain lung diseases.
- These results provide insights into the pathogenesis of lung inflammation driven by specific bacterial components.
More Related Videos
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
01:19Formation of Lipopolysaccharides